In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid μ-agonist/δ-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence

Journal of Pharmacology and Experimental Therapeutics

Volumn 297, Issue 2, 2001, Pages 597-605

  Wells, Jennifer L ^a   Bartlett, Jeffrey L ^a   Ananthan, Subramaniam ^b   Bilsky, Edward J ^a  

^a UNIVERSITY OF NORTHERN COLORADO   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA FUNALTREXAMINE; DELTORPHIN; MORPHINE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE AGONIST; SORI 9409; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST; WRITHING TEST;

ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED ICR; MORPHINE; MORPHINE DEPENDENCE; MORPHINE DERIVATIVES; NALOXONE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; PAIN MEASUREMENT; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 0035040627     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice
2. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans
3. Effects of neutral and negative antagonists and protein kinase inhibitors on acute morphine dependence and antinociceptive tolerance in mice
4. The effect of intrinsic efficacy on opioid tolerance
5. Comparison of buprenorphine and methadone maintenance in opiate addicts
6. Opioid analgesics for cancer pain: Toxicities and their treatments
7. 5-HT4 receptor agonists and delta-opioid receptor antagonists act synergistically to stimulate colonic propulsion
8. The delta receptor is involved in sufentanil-induced respiratory depression-opioid subreceptors mediate different effects
9. Opioid reinforcement in heroin-dependent volunteers during outpatient buprenorphine maintenance
10. Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test
11. The inhibitory effects of fentanyl and other morphine-like analgesics on the warm water-induced tail-withdrawal reflex in rats
12. 6]enkephalin and naltrindole 5′-isothiocyanate: Evidence for delta receptor subtypes
13. Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice
14. Involvement of delta 2 opioid receptors in the development of morphine dependence in mice
15. Involvement of delta 2 opioid receptors in acute dependence on morphine in mice
16. Heritability of nociception I: Responses of 11 inbred mouse strains on 12 measures of nociception
17. Dezocine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy
18. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic
19. Opioids in acute and chronic pain: Lessons from the cloned receptors
20. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse
21. Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist
22. Abuse liability studies of opioid agonist-antagonists in humans
23. Cocaine self-administration and naltrindole, a delta-selective opioid antagonist
24. Naltrindole, an opioid delta receptor antagonist, blocks cocaine-induced facilitation of responding for rewarding brain stimulation
25. The opioid mu agonist/delta antagonist DIPP-NH(2)[y] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats
26. Differential cross-tolerance between intrathecal morphine and sufentanil in the rat
27. Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion
28. Opioid antagonist effects of dezocine in opioid-dependent humans
29. Buprenorphine versus methadone in the treatment of opioid dependence: Self-reports, urinalysis, and addiction severity index
30. Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception
31. Effect of naltrindole on the development of physical dependence on morphine in mice: A behavioral and biochemical study
32. Involvement of delta 1 and delta 2 opioid receptor subtypes in the development of physical dependence on morphine in mice
33. Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine
34. Retention of supraspinal delta-like analgesia and loss of morphine tolerance in δ opioid receptor knockout mice